Amplifica raises $26M Series B to develop injectable hair-growth therapies

What's the deal? Amplifica, a San Diego clinical-stage biopharmaceutical company developing treatments for hair loss, has closed an oversubscribed $26 million Series B financing. The company will use the proceeds to advance its injectable pipeline through clinical development.

How it works: Amplifica is developing signalling molecules designed to reactivate dormant hair follicles and stimulate new hair growth, offering an approach that differs from products focused mainly on slowing further hair loss.

Investor backing: Eli LillyDealroom has a profile for this one. Try Dealroom → participated alongside new and existing investors, including Scopia Capital ManagementDealroom has a profile for this one. Try Dealroom →.

The signal: The financing gives Amplifica capital to move its hair-growth candidates through clinical development as the company targets a large unmet need in androgenetic alopecia.

Image credit: Amplifica

Read more: PR Newswire